Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Language
Publication year range
1.
An. bras. dermatol ; 97(1): 89-92, Jan.-Feb. 2022. graf
Article in English | LILACS | ID: biblio-1360083

ABSTRACT

Abstract Cutaneous leishmaniasis represents a public health problem that affects 85 countries. It is an endemic disease in Brazil, having an important socioeconomic impact. An exuberant case of cutaneous leishmaniasis is reported herein. A 28-year-old male patient with Down syndrome had had verrucous plaques on the back for over a year, with progressive growth. PCR of a lesion sample was positive for Leishmania braziliensis. The patient's condition was classified as atypical cutaneous leishmaniasis. He was successfully treated with amphotericin B and miltefosine. The treatment remains a challenge, given the toxicity and low cure rate of the currently recommended drugs.


Subject(s)
Humans , Male , Adult , Leishmania braziliensis , Leishmaniasis, Cutaneous/drug therapy , Leishmaniasis, Cutaneous/epidemiology , Antiprotozoal Agents/therapeutic use , Amphotericin B/therapeutic use , Endemic Diseases
2.
An Bras Dermatol ; 97(1): 89-92, 2022.
Article in English | MEDLINE | ID: mdl-34839986

ABSTRACT

Cutaneous leishmaniasis represents a public health problem that affects 85 countries. It is an endemic disease in Brazil, having an important socioeconomic impact. An exuberant case of cutaneous leishmaniasis is reported herein. A 28-year-old male patient with Down syndrome had had verrucous plaques on the back for over a year, with progressive growth. PCR of a lesion sample was positive for Leishmania braziliensis. The patient's condition was classified as atypical cutaneous leishmaniasis. He was successfully treated with amphotericin B and miltefosine. The treatment remains a challenge, given the toxicity and low cure rate of the currently recommended drugs.


Subject(s)
Antiprotozoal Agents , Leishmania braziliensis , Leishmaniasis, Cutaneous , Adult , Amphotericin B/therapeutic use , Antiprotozoal Agents/therapeutic use , Endemic Diseases , Humans , Leishmaniasis, Cutaneous/drug therapy , Leishmaniasis, Cutaneous/epidemiology , Male
4.
An Bras Dermatol ; 92(1): 110-112, 2017.
Article in English | MEDLINE | ID: mdl-28225968

ABSTRACT

Blue nevus is a benign melanocytic lesion whose most frequent variants are dendritic (common) blue nevus and cellular blue nevus. Atypical cellular blue nevus presents an intermediate histopathology between the typical and a rare variant of malignant blue nevus/melanoma arising in a cellular blue nevus. An 8-year-old child presented a pigmented lesion in the buttock since birth, but with progressive growth in the last two years. After surgical excision, histopathological examination revealed atypical cellular blue nevus. Presence of mitoses, ulceration, infiltration, cytological atypia or necrosis may occur in atypical cellular blue nevus, making it difficult to differentiate it from melanoma. The growth of blue nevus is unusual and considered of high-risk for malignancy, being an indicator for complete resection and periodic follow-up of these patients.


Subject(s)
Nevus, Blue/pathology , Child , Diagnosis, Differential , Humans , Male , Skin Neoplasms/pathology
5.
An. bras. dermatol ; 92(1): 110-112, Jan.-Feb. 2017. graf
Article in English | LILACS | ID: biblio-838025

ABSTRACT

Abstract: Blue nevus is a benign melanocytic lesion whose most frequent variants are dendritic (common) blue nevus and cellular blue nevus. Atypical cellular blue nevus presents an intermediate histopathology between the typical and a rare variant of malignant blue nevus/melanoma arising in a cellular blue nevus. An 8-year-old child presented a pigmented lesion in the buttock since birth, but with progressive growth in the last two years. After surgical excision, histopathological examination revealed atypical cellular blue nevus. Presence of mitoses, ulceration, infiltration, cytological atypia or necrosis may occur in atypical cellular blue nevus, making it difficult to differentiate it from melanoma. The growth of blue nevus is unusual and considered of high-risk for malignancy, being an indicator for complete resection and periodic follow-up of these patients.


Subject(s)
Humans , Male , Child , Nevus, Blue/pathology , Skin Neoplasms/pathology , Diagnosis, Differential
SELECTION OF CITATIONS
SEARCH DETAIL